

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | transepithelial transport (GO:0070633) | 8.55273407 |
| 2 | desmosome organization (GO:0002934) | 7.86571906 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.33531228 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.33531228 |
| 5 | cellular copper ion homeostasis (GO:0006878) | 7.06943023 |
| 6 | positive regulation of keratinocyte differentiation (GO:0045618) | 6.75349891 |
| 7 | hemidesmosome assembly (GO:0031581) | 6.34300422 |
| 8 | regulation of water loss via skin (GO:0033561) | 6.03256335 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.98964684 |
| 10 | ear development (GO:0043583) | 5.81012959 |
| 11 | copper ion transport (GO:0006825) | 5.70547061 |
| 12 | copper ion homeostasis (GO:0055070) | 5.66561641 |
| 13 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.54765399 |
| 14 | positive regulation of epidermal cell differentiation (GO:0045606) | 5.43136831 |
| 15 | excretion (GO:0007588) | 5.36483560 |
| 16 | sperm capacitation (GO:0048240) | 5.29180874 |
| 17 | establishment of skin barrier (GO:0061436) | 5.08320655 |
| 18 | hepatocyte apoptotic process (GO:0097284) | 5.07434725 |
| 19 | cytidine deamination (GO:0009972) | 4.95625338 |
| 20 | cytidine metabolic process (GO:0046087) | 4.95625338 |
| 21 | cytidine catabolic process (GO:0006216) | 4.95625338 |
| 22 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 4.89062651 |
| 23 | opioid receptor signaling pathway (GO:0038003) | 4.87460030 |
| 24 | bicarbonate transport (GO:0015701) | 4.86131473 |
| 25 | iron ion import (GO:0097286) | 4.85320224 |
| 26 | semaphorin-plexin signaling pathway (GO:0071526) | 4.84020306 |
| 27 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.65488135 |
| 28 | multicellular organismal water homeostasis (GO:0050891) | 4.52757146 |
| 29 | trivalent inorganic cation transport (GO:0072512) | 4.51832587 |
| 30 | ferric iron transport (GO:0015682) | 4.51832587 |
| 31 | pattern specification involved in kidney development (GO:0061004) | 4.37373028 |
| 32 | response to water (GO:0009415) | 4.34204986 |
| 33 | negative regulation of protein oligomerization (GO:0032460) | 4.33956317 |
| 34 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.25645389 |
| 35 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.23424426 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.20194101 |
| 37 | L-phenylalanine catabolic process (GO:0006559) | 4.20194101 |
| 38 | positive regulation of epidermis development (GO:0045684) | 4.17573304 |
| 39 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.16869548 |
| 40 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.14356358 |
| 41 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.11295580 |
| 42 | metanephric mesenchyme development (GO:0072075) | 4.08470531 |
| 43 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.05738606 |
| 44 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.05738606 |
| 45 | biotin metabolic process (GO:0006768) | 4.03463524 |
| 46 | interferon-gamma secretion (GO:0072643) | 4.03069676 |
| 47 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.00282613 |
| 48 | intestinal epithelial cell development (GO:0060576) | 3.97914267 |
| 49 | tryptophan metabolic process (GO:0006568) | 3.92319652 |
| 50 | L-phenylalanine metabolic process (GO:0006558) | 3.88147280 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.88147280 |
| 52 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.84609420 |
| 53 | regulation of keratinocyte differentiation (GO:0045616) | 3.80537002 |
| 54 | nephron epithelium morphogenesis (GO:0072088) | 3.80143117 |
| 55 | nephron tubule morphogenesis (GO:0072078) | 3.80143117 |
| 56 | water homeostasis (GO:0030104) | 3.73867886 |
| 57 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.73274409 |
| 58 | type B pancreatic cell proliferation (GO:0044342) | 3.69151991 |
| 59 | epithelial cell-cell adhesion (GO:0090136) | 3.68963380 |
| 60 | L-serine transport (GO:0015825) | 3.68255753 |
| 61 | regulation of intracellular pH (GO:0051453) | 3.67175787 |
| 62 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.66591015 |
| 63 | bone remodeling (GO:0046849) | 3.65854746 |
| 64 | lysine metabolic process (GO:0006553) | 3.65416243 |
| 65 | lysine catabolic process (GO:0006554) | 3.65416243 |
| 66 | amyloid precursor protein metabolic process (GO:0042982) | 3.64831367 |
| 67 | cell-substrate junction assembly (GO:0007044) | 3.62163844 |
| 68 | urate metabolic process (GO:0046415) | 3.61520021 |
| 69 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.60835219 |
| 70 | transferrin transport (GO:0033572) | 3.60310146 |
| 71 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.59289777 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.56734048 |
| 73 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.55276662 |
| 74 | negative regulation of cell size (GO:0045792) | 3.54139508 |
| 75 | kidney mesenchyme development (GO:0072074) | 3.53791551 |
| 76 | import into cell (GO:0098657) | 3.53503947 |
| 77 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.53082279 |
| 78 | membrane hyperpolarization (GO:0060081) | 3.52544586 |
| 79 | establishment of apical/basal cell polarity (GO:0035089) | 3.50110371 |
| 80 | myoblast migration (GO:0051451) | 3.49877794 |
| 81 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.48456070 |
| 82 | amyloid precursor protein catabolic process (GO:0042987) | 3.46762458 |
| 83 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.46393306 |
| 84 | glyoxylate metabolic process (GO:0046487) | 3.44775185 |
| 85 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.39892427 |
| 86 | norepinephrine metabolic process (GO:0042415) | 3.39337422 |
| 87 | striated muscle atrophy (GO:0014891) | 3.38826712 |
| 88 | regulation of cellular pH (GO:0030641) | 3.38105282 |
| 89 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.37272074 |
| 90 | synaptonemal complex assembly (GO:0007130) | 3.35946118 |
| 91 | cell differentiation involved in metanephros development (GO:0072202) | 3.35814458 |
| 92 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.34400031 |
| 93 | negative regulation of microtubule polymerization (GO:0031115) | 3.34370561 |
| 94 | cardiac right ventricle morphogenesis (GO:0003215) | 3.33463243 |
| 95 | water transport (GO:0006833) | 3.33259578 |
| 96 | atrioventricular valve morphogenesis (GO:0003181) | 3.32130811 |
| 97 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.31016638 |
| 98 | organic cation transport (GO:0015695) | 3.30488257 |
| 99 | sodium ion homeostasis (GO:0055078) | 3.27964982 |
| 100 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.26864948 |
| 101 | phosphate ion homeostasis (GO:0055062) | 3.26120240 |
| 102 | trivalent inorganic anion homeostasis (GO:0072506) | 3.26120240 |
| 103 | endothelial cell chemotaxis (GO:0035767) | 3.23509053 |
| 104 | regulation of interleukin-13 production (GO:0032656) | 3.22845144 |
| 105 | kynurenine metabolic process (GO:0070189) | 3.22765130 |
| 106 | molting cycle (GO:0042303) | 3.22566020 |
| 107 | hair cycle (GO:0042633) | 3.22566020 |
| 108 | maternal placenta development (GO:0001893) | 3.22122787 |
| 109 | vagina development (GO:0060068) | 3.20753744 |
| 110 | epidermis development (GO:0008544) | 3.19837057 |
| 111 | serine transport (GO:0032329) | 3.18582976 |
| 112 | response to copper ion (GO:0046688) | 3.18473932 |
| 113 | negative regulation of cell fate specification (GO:0009996) | 3.18328397 |
| 114 | drug transmembrane transport (GO:0006855) | 3.16771112 |
| 115 | regulation of protein localization to cell surface (GO:2000008) | 3.15230143 |
| 116 | positive regulation of protein homooligomerization (GO:0032464) | 3.14997257 |
| 117 | tricarboxylic acid metabolic process (GO:0072350) | 3.14201800 |
| 118 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.13766906 |
| 119 | iron ion transport (GO:0006826) | 3.11979609 |
| 120 | regulation of pH (GO:0006885) | 3.11511177 |
| 121 | mesonephros development (GO:0001823) | 3.10962342 |
| 122 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.10812322 |
| 123 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 3.09326457 |
| 124 | quaternary ammonium group transport (GO:0015697) | 3.08194823 |
| 125 | apoptotic process involved in morphogenesis (GO:0060561) | 3.08048243 |
| 126 | vesicle targeting (GO:0006903) | 3.07390146 |
| 127 | cell-substrate adherens junction assembly (GO:0007045) | 3.06555348 |
| 128 | focal adhesion assembly (GO:0048041) | 3.06555348 |
| 129 | indole-containing compound catabolic process (GO:0042436) | 3.06466191 |
| 130 | indolalkylamine catabolic process (GO:0046218) | 3.06466191 |
| 131 | tryptophan catabolic process (GO:0006569) | 3.06466191 |
| 132 | keratinocyte development (GO:0003334) | 3.05636246 |
| 133 | phosphate ion transport (GO:0006817) | 3.05629544 |
| 134 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.04563439 |
| 135 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.04252464 |
| 136 | activation of Rac GTPase activity (GO:0032863) | 3.03926483 |
| 137 | cellular modified amino acid catabolic process (GO:0042219) | 3.02414331 |
| 138 | regulation of cardioblast differentiation (GO:0051890) | 3.00255731 |
| 139 | regulation of female gonad development (GO:2000194) | 3.00098626 |
| 140 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.98860253 |
| 141 | renal tubule morphogenesis (GO:0061333) | 2.97790734 |
| 142 | skeletal muscle adaptation (GO:0043501) | 2.97048379 |
| 143 | monovalent inorganic cation homeostasis (GO:0055067) | 2.95760874 |
| 144 | response to food (GO:0032094) | 2.94852655 |
| 145 | negative regulation of Ras GTPase activity (GO:0034261) | 2.94004701 |
| 146 | response to mercury ion (GO:0046689) | 2.92816743 |
| 147 | 2-oxoglutarate metabolic process (GO:0006103) | 2.92275276 |
| 148 | short-chain fatty acid metabolic process (GO:0046459) | 2.91585853 |
| 149 | fluid transport (GO:0042044) | 2.88325316 |
| 150 | pH reduction (GO:0045851) | 2.88144010 |
| 151 | phagosome maturation (GO:0090382) | 2.87897111 |
| 152 | cornea development in camera-type eye (GO:0061303) | 2.86376419 |
| 153 | negative regulation of kidney development (GO:0090185) | 2.85901271 |
| 154 | amino-acid betaine transport (GO:0015838) | 2.85310659 |
| 155 | carnitine transport (GO:0015879) | 2.85310659 |
| 156 | positive regulation of mesonephros development (GO:0061213) | 2.85018614 |
| 157 | COPI coating of Golgi vesicle (GO:0048205) | 2.84221261 |
| 158 | Golgi transport vesicle coating (GO:0048200) | 2.84221261 |
| 159 | embryonic eye morphogenesis (GO:0048048) | 2.84169698 |
| 160 | aromatic amino acid family catabolic process (GO:0009074) | 2.82423958 |
| 161 | muscle atrophy (GO:0014889) | 2.82423362 |
| 162 | aspartate family amino acid catabolic process (GO:0009068) | 2.81913345 |
| 163 | alpha-linolenic acid metabolic process (GO:0036109) | 2.81776041 |
| 164 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.81543092 |
| 165 | regulation of epidermal cell differentiation (GO:0045604) | 2.80929993 |
| 166 | vasodilation (GO:0042311) | 2.80686512 |
| 167 | O-glycan processing (GO:0016266) | 2.80661479 |
| 168 | ectoderm development (GO:0007398) | 2.78316786 |
| 169 | surfactant homeostasis (GO:0043129) | 2.78254033 |
| 170 | adherens junction assembly (GO:0034333) | 2.75441994 |
| 171 | regulation of epidermis development (GO:0045682) | 2.74622742 |
| 172 | sensory perception of taste (GO:0050909) | 2.74175335 |
| 173 | synaptonemal complex organization (GO:0070193) | 2.73831437 |
| 174 | establishment of monopolar cell polarity (GO:0061162) | 2.72578225 |
| 175 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.72578225 |
| 176 | apical protein localization (GO:0045176) | 2.72103351 |
| 177 | positive regulation of odontogenesis (GO:0042482) | 2.71680104 |
| 178 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.71421429 |
| 179 | indolalkylamine metabolic process (GO:0006586) | 2.71295153 |
| 180 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.71023118 |
| 181 | epithelial cell maturation (GO:0002070) | 2.68524212 |
| 182 | negative regulation of cell fate commitment (GO:0010454) | 2.68498935 |
| 183 | establishment of tissue polarity (GO:0007164) | 2.66604858 |
| 184 | establishment of planar polarity (GO:0001736) | 2.66604858 |
| 185 | hair follicle development (GO:0001942) | 2.66186572 |
| 186 | regulation of establishment of cell polarity (GO:2000114) | 2.65424024 |
| 187 | trophectodermal cell differentiation (GO:0001829) | 2.65252627 |
| 188 | negative regulation of cell junction assembly (GO:1901889) | 2.65124783 |
| 189 | phenylpropanoid metabolic process (GO:0009698) | 2.64115085 |
| 190 | fatty acid beta-oxidation (GO:0006635) | 2.63833803 |
| 191 | regulation of mesonephros development (GO:0061217) | 2.62219738 |
| 192 | proline metabolic process (GO:0006560) | 2.60379531 |
| 193 | cellular response to toxic substance (GO:0097237) | 2.59841568 |
| 194 | ganglion development (GO:0061548) | 2.59046243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 5.30522091 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.62309807 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.42744002 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.34002674 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.18995145 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.14395297 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.84946033 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.78305356 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.66473072 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.53786798 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46008178 |
| 12 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.44254731 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.38119621 |
| 14 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.28971877 |
| 15 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.27557659 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.20261148 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19050283 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16233695 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.15395026 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.04832729 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.02031164 |
| 22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.91469817 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.89286871 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.85328409 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84878891 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83998497 |
| 27 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.81396406 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76471755 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75083355 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.74785415 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73583103 |
| 32 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73542198 |
| 33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71757362 |
| 34 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.68539186 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.67927586 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66642794 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62696752 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61578054 |
| 39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58729456 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56666814 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54482070 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53345728 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53142879 |
| 44 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52074626 |
| 45 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.48364432 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48114456 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45779610 |
| 48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.45574296 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44044000 |
| 50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41347132 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37576734 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.37005490 |
| 53 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36270122 |
| 54 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34329464 |
| 55 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.33064075 |
| 56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.32264706 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32087718 |
| 58 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31793187 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31752562 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31563356 |
| 61 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.31302568 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31028474 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.30730395 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30302861 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30286591 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30285296 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27499335 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26339971 |
| 69 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25625767 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24457607 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23387232 |
| 72 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.23065022 |
| 73 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21629664 |
| 74 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21246269 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20719249 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19781843 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18966656 |
| 78 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17433284 |
| 79 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.16988765 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15036371 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15008868 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14714549 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14688185 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14020638 |
| 85 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13408358 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10008320 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08794358 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08288817 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07021608 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06070278 |
| 91 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04854559 |
| 92 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03520297 |
| 93 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03205420 |
| 94 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.02291484 |
| 95 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02246806 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01927876 |
| 97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01927876 |
| 98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01907915 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01730541 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01518836 |
| 101 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01357823 |
| 102 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00933213 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98715830 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98423812 |
| 105 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98288430 |
| 106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98253659 |
| 107 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.97794554 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97684173 |
| 109 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97336878 |
| 110 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97068965 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97057475 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97057475 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96941475 |
| 114 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96255609 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96114126 |
| 116 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95854660 |
| 117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95775161 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95070300 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94593131 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93391542 |
| 121 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92082338 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91964528 |
| 123 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91377083 |
| 124 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90494772 |
| 125 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90418373 |
| 126 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90418373 |
| 127 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90406508 |
| 128 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88935726 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88328123 |
| 130 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.87926419 |
| 131 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.87892377 |
| 132 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86922952 |
| 133 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.86512123 |
| 134 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.86512123 |
| 135 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.86512123 |
| 136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85817450 |
| 137 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85765392 |
| 138 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.85523494 |
| 139 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.85400774 |
| 140 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.84846730 |
| 141 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84398230 |
| 142 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.84396794 |
| 143 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84309040 |
| 144 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83787209 |
| 145 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82955448 |
| 146 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.82836676 |
| 147 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.82645169 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82511849 |
| 149 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82206714 |
| 150 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81920865 |
| 151 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81495685 |
| 152 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81268626 |
| 153 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.80969985 |
| 154 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80104365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 6.87546480 |
| 2 | MP0002163_abnormal_gland_morphology | 5.90520625 |
| 3 | MP0000579_abnormal_nail_morphology | 4.95760646 |
| 4 | MP0004742_abnormal_vestibular_system | 4.85864991 |
| 5 | * MP0004885_abnormal_endolymph | 4.73332202 |
| 6 | MP0004381_abnormal_hair_follicle | 4.02944520 |
| 7 | MP0002132_abnormal_respiratory_system | 3.95842971 |
| 8 | MP0005379_endocrine/exocrine_gland_phen | 3.28916353 |
| 9 | MP0008872_abnormal_physiological_respon | 3.23389054 |
| 10 | MP0000462_abnormal_digestive_system | 3.17214244 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 3.16419029 |
| 12 | MP0005076_abnormal_cell_differentiation | 3.10051872 |
| 13 | MP0000383_abnormal_hair_follicle | 2.99008529 |
| 14 | MP0000566_synostosis | 2.97977603 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.95419095 |
| 16 | MP0002089_abnormal_postnatal_growth/wei | 2.88929957 |
| 17 | MP0002277_abnormal_respiratory_mucosa | 2.82914696 |
| 18 | MP0000467_abnormal_esophagus_morphology | 2.73892442 |
| 19 | MP0004043_abnormal_pH_regulation | 2.56104525 |
| 20 | MP0000377_abnormal_hair_follicle | 2.47969239 |
| 21 | MP0005360_urolithiasis | 2.46722486 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.46423059 |
| 23 | MP0001177_atelectasis | 2.39865107 |
| 24 | MP0001216_abnormal_epidermal_layer | 2.31881744 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 2.31463188 |
| 26 | MP0005408_hypopigmentation | 2.29948044 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 2.27878302 |
| 28 | MP0003878_abnormal_ear_physiology | 2.27878302 |
| 29 | MP0005171_absent_coat_pigmentation | 2.22294091 |
| 30 | MP0002060_abnormal_skin_morphology | 2.06146832 |
| 31 | MP0000613_abnormal_salivary_gland | 1.96715178 |
| 32 | MP0005220_abnormal_exocrine_pancreas | 1.95711448 |
| 33 | MP0001270_distended_abdomen | 1.92094441 |
| 34 | MP0008260_abnormal_autophagy | 1.89105097 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.85139784 |
| 36 | * MP0009643_abnormal_urine_homeostasis | 1.81310967 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.79218915 |
| 38 | MP0001881_abnormal_mammary_gland | 1.77953684 |
| 39 | MP0010771_integument_phenotype | 1.75110998 |
| 40 | MP0003195_calcinosis | 1.75001878 |
| 41 | MP0000762_abnormal_tongue_morphology | 1.70542433 |
| 42 | MP0005332_abnormal_amino_acid | 1.69404175 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.65472822 |
| 44 | MP0005409_darkened_coat_color | 1.65460042 |
| 45 | MP0001765_abnormal_ion_homeostasis | 1.63694638 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.59460823 |
| 47 | MP0001663_abnormal_digestive_system | 1.57819949 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.56726389 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.56293232 |
| 50 | MP0000427_abnormal_hair_cycle | 1.56253808 |
| 51 | MP0003329_amyloid_beta_deposits | 1.55646316 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.50185903 |
| 53 | MP0001756_abnormal_urination | 1.46320644 |
| 54 | MP0002254_reproductive_system_inflammat | 1.44236394 |
| 55 | MP0009931_abnormal_skin_appearance | 1.34908710 |
| 56 | MP0004147_increased_porphyrin_level | 1.32756466 |
| 57 | MP0001849_ear_inflammation | 1.30893520 |
| 58 | MP0002233_abnormal_nose_morphology | 1.26419560 |
| 59 | MP0002098_abnormal_vibrissa_morphology | 1.25905739 |
| 60 | MP0000371_diluted_coat_color | 1.25828132 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.23920489 |
| 62 | MP0001984_abnormal_olfaction | 1.23495855 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.23312330 |
| 64 | MP0000372_irregular_coat_pigmentation | 1.22540142 |
| 65 | MP0005381_digestive/alimentary_phenotyp | 1.20819501 |
| 66 | * MP0002136_abnormal_kidney_physiology | 1.16419189 |
| 67 | MP0002133_abnormal_respiratory_system | 1.14925920 |
| 68 | MP0005388_respiratory_system_phenotype | 1.14925920 |
| 69 | MP0000367_abnormal_coat/_hair | 1.14405105 |
| 70 | MP0003638_abnormal_response/metabolism_ | 1.14293771 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.09553604 |
| 72 | MP0002938_white_spotting | 1.06761676 |
| 73 | MP0002168_other_aberrant_phenotype | 1.06177981 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.05441279 |
| 75 | MP0003936_abnormal_reproductive_system | 1.03355869 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.02513801 |
| 77 | MP0000647_abnormal_sebaceous_gland | 1.01650839 |
| 78 | * MP0001963_abnormal_hearing_physiology | 1.01396932 |
| 79 | MP0003866_abnormal_defecation | 0.99559113 |
| 80 | MP0000534_abnormal_ureter_morphology | 0.99037825 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.98884773 |
| 82 | MP0004233_abnormal_muscle_weight | 0.96864351 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.96845568 |
| 84 | MP0003045_fibrosis | 0.95573399 |
| 85 | MP0004272_abnormal_basement_membrane | 0.94259200 |
| 86 | MP0003942_abnormal_urinary_system | 0.91864184 |
| 87 | MP0001340_abnormal_eyelid_morphology | 0.91672440 |
| 88 | MP0001873_stomach_inflammation | 0.88852657 |
| 89 | MP0009840_abnormal_foam_cell | 0.87935655 |
| 90 | MP0005423_abnormal_somatic_nervous | 0.86929801 |
| 91 | MP0003941_abnormal_skin_development | 0.86819769 |
| 92 | MP0005275_abnormal_skin_tensile | 0.86681481 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.85433101 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.85431554 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.84526942 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 0.83646647 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.81883013 |
| 98 | MP0001191_abnormal_skin_condition | 0.81416651 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.80466133 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.78935956 |
| 101 | MP0001664_abnormal_digestion | 0.78595457 |
| 102 | MP0000604_amyloidosis | 0.78524039 |
| 103 | MP0002009_preneoplasia | 0.77850768 |
| 104 | MP0002108_abnormal_muscle_morphology | 0.77755048 |
| 105 | MP0009672_abnormal_birth_weight | 0.77717711 |
| 106 | MP0002282_abnormal_trachea_morphology | 0.77364117 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.77055158 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.76814748 |
| 109 | MP0005083_abnormal_biliary_tract | 0.75042103 |
| 110 | MP0008569_lethality_at_weaning | 0.74560758 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.74474754 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.74459210 |
| 113 | MP0004947_skin_inflammation | 0.74182523 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.73266577 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.73024852 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.72371400 |
| 117 | MP0000537_abnormal_urethra_morphology | 0.72099614 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.71819303 |
| 119 | MP0005451_abnormal_body_composition | 0.70938863 |
| 120 | MP0000470_abnormal_stomach_morphology | 0.69598586 |
| 121 | MP0001958_emphysema | 0.65649323 |
| 122 | MP0003191_abnormal_cellular_cholesterol | 0.65379202 |
| 123 | MP0003690_abnormal_glial_cell | 0.63534563 |
| 124 | MP0005395_other_phenotype | 0.63305231 |
| 125 | MP0002796_impaired_skin_barrier | 0.63189823 |
| 126 | MP0003693_abnormal_embryo_hatching | 0.63084971 |
| 127 | MP0003115_abnormal_respiratory_system | 0.63058223 |
| 128 | MP0000858_altered_metastatic_potential | 0.62886267 |
| 129 | MP0005310_abnormal_salivary_gland | 0.62132160 |
| 130 | MP0002933_joint_inflammation | 0.60482533 |
| 131 | MP0005365_abnormal_bile_salt | 0.60459840 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.60143105 |
| 133 | MP0001666_abnormal_nutrient_absorption | 0.59361644 |
| 134 | MP0003123_paternal_imprinting | 0.57539245 |
| 135 | * MP0001485_abnormal_pinna_reflex | 0.56736375 |
| 136 | MP0002118_abnormal_lipid_homeostasis | 0.55915738 |
| 137 | MP0002909_abnormal_adrenal_gland | 0.52917897 |
| 138 | * MP0002116_abnormal_craniofacial_bone | 0.52739228 |
| 139 | MP0005647_abnormal_sex_gland | 0.51002250 |
| 140 | MP0005621_abnormal_cell_physiology | 0.50646414 |
| 141 | MP0005508_abnormal_skeleton_morphology | 0.50330148 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.50307763 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49117159 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.47843227 |
| 145 | MP0005023_abnormal_wound_healing | 0.47422351 |
| 146 | MP0000627_abnormal_mammary_gland | 0.47111571 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.46958178 |
| 148 | MP0008875_abnormal_xenobiotic_pharmacok | 0.46814696 |
| 149 | MP0002970_abnormal_white_adipose | 0.45754788 |
| 150 | MP0010630_abnormal_cardiac_muscle | 0.45695995 |
| 151 | MP0003763_abnormal_thymus_physiology | 0.45301778 |
| 152 | MP0004858_abnormal_nervous_system | 0.44624798 |
| 153 | MP0002751_abnormal_autonomic_nervous | 0.42978196 |
| 154 | MP0010329_abnormal_lipoprotein_level | 0.42954094 |
| 155 | MP0005501_abnormal_skin_physiology | 0.42844663 |
| 156 | * MP0002135_abnormal_kidney_morphology | 0.41920842 |
| 157 | MP0010678_abnormal_skin_adnexa | 0.41874919 |
| 158 | MP0002653_abnormal_ependyma_morphology | 0.41199385 |
| 159 | MP0003879_abnormal_hair_cell | 0.40529364 |
| 160 | MP0003252_abnormal_bile_duct | 0.38373628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypokalemic alkalosis (HP:0001949) | 8.82043480 |
| 2 | * Morphological abnormality of the inner ear (HP:0011390) | 8.50390138 |
| 3 | Ileus (HP:0002595) | 7.58281678 |
| 4 | Renal salt wasting (HP:0000127) | 7.17094606 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.11206601 |
| 6 | Metabolic alkalosis (HP:0200114) | 6.97081761 |
| 7 | Hyperaldosteronism (HP:0000859) | 6.93650759 |
| 8 | Rectal prolapse (HP:0002035) | 6.37622344 |
| 9 | Male infertility (HP:0003251) | 6.30753566 |
| 10 | Tinnitus (HP:0000360) | 5.13418612 |
| 11 | Abnormality of the right ventricle (HP:0001707) | 4.91273094 |
| 12 | Alkalosis (HP:0001948) | 4.88281017 |
| 13 | Hyponatremia (HP:0002902) | 4.63438328 |
| 14 | Polyuria (HP:0000103) | 4.59171917 |
| 15 | Abnormality of sodium homeostasis (HP:0010931) | 4.28237422 |
| 16 | Hypercalciuria (HP:0002150) | 4.28199164 |
| 17 | Abnormal urine output (HP:0012590) | 4.28034334 |
| 18 | Fragile nails (HP:0001808) | 4.20571377 |
| 19 | Abnormality of renal excretion (HP:0011036) | 4.20484816 |
| 20 | Tubulointerstitial fibrosis (HP:0005576) | 4.18525259 |
| 21 | Abnormality of nail color (HP:0100643) | 4.17848619 |
| 22 | J-shaped sella turcica (HP:0002680) | 4.16937937 |
| 23 | Concave nail (HP:0001598) | 4.10851726 |
| 24 | Chronic bronchitis (HP:0004469) | 4.07624715 |
| 25 | Hypokalemia (HP:0002900) | 3.97419816 |
| 26 | Azoospermia (HP:0000027) | 3.83519403 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 3.71158620 |
| 28 | Micronodular cirrhosis (HP:0001413) | 3.70815904 |
| 29 | Milia (HP:0001056) | 3.68312293 |
| 30 | Amelogenesis imperfecta (HP:0000705) | 3.59882331 |
| 31 | Septate vagina (HP:0001153) | 3.55461866 |
| 32 | Adrenal overactivity (HP:0002717) | 3.55219516 |
| 33 | Abnormality of potassium homeostasis (HP:0011042) | 3.33002830 |
| 34 | Broad face (HP:0000283) | 3.28949055 |
| 35 | Plantar hyperkeratosis (HP:0007556) | 3.26292055 |
| 36 | Lip pit (HP:0100267) | 3.22949104 |
| 37 | Decreased circulating renin level (HP:0003351) | 3.17032589 |
| 38 | Renal tubular acidosis (HP:0001947) | 3.16543162 |
| 39 | Hyperkalemia (HP:0002153) | 3.15978750 |
| 40 | Hypotrichosis (HP:0001006) | 3.13117134 |
| 41 | Sparse lateral eyebrow (HP:0005338) | 2.98739949 |
| 42 | Abdominal distention (HP:0003270) | 2.93439829 |
| 43 | Advanced eruption of teeth (HP:0006288) | 2.92937029 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.87674256 |
| 45 | Nail dystrophy (HP:0008404) | 2.86449990 |
| 46 | Increased circulating renin level (HP:0000848) | 2.86384508 |
| 47 | Woolly hair (HP:0002224) | 2.86242412 |
| 48 | Dehydration (HP:0001944) | 2.82750694 |
| 49 | Selective tooth agenesis (HP:0001592) | 2.80424769 |
| 50 | Abnormal hair laboratory examination (HP:0003328) | 2.77620762 |
| 51 | Thick nail (HP:0001805) | 2.74657604 |
| 52 | Exocrine pancreatic insufficiency (HP:0001738) | 2.73855655 |
| 53 | Vascular calcification (HP:0004934) | 2.67196323 |
| 54 | Abnormal spermatogenesis (HP:0008669) | 2.67023499 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.65318951 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.64420696 |
| 57 | Hypothermia (HP:0002045) | 2.59877072 |
| 58 | Ridged nail (HP:0001807) | 2.58589717 |
| 59 | Atrophic scars (HP:0001075) | 2.57806954 |
| 60 | Tubulointerstitial abnormality (HP:0001969) | 2.55102241 |
| 61 | Flat acetabular roof (HP:0003180) | 2.54291420 |
| 62 | Large eyes (HP:0001090) | 2.51470544 |
| 63 | Short nail (HP:0001799) | 2.49789033 |
| 64 | Glomerulosclerosis (HP:0000096) | 2.49456358 |
| 65 | Pterygium (HP:0001059) | 2.48850069 |
| 66 | Gout (HP:0001997) | 2.47458813 |
| 67 | Abnormality of the dental pulp (HP:0006479) | 2.45983034 |
| 68 | Deformed sella turcica (HP:0002681) | 2.45780472 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.45494536 |
| 70 | Osteomalacia (HP:0002749) | 2.45448835 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.45188860 |
| 72 | Gastrointestinal dysmotility (HP:0002579) | 2.44744231 |
| 73 | Cervical subluxation (HP:0003308) | 2.42918736 |
| 74 | Diaphragmatic weakness (HP:0009113) | 2.41819508 |
| 75 | Curly hair (HP:0002212) | 2.39741449 |
| 76 | Aplasia cutis congenita (HP:0001057) | 2.38050504 |
| 77 | Absent frontal sinuses (HP:0002688) | 2.36979317 |
| 78 | Lymphangioma (HP:0100764) | 2.35810837 |
| 79 | Abnormality of the dental root (HP:0006486) | 2.35661617 |
| 80 | Taurodontia (HP:0000679) | 2.35661617 |
| 81 | Abnormality of permanent molar morphology (HP:0011071) | 2.35661617 |
| 82 | Bronchiectasis (HP:0002110) | 2.35492620 |
| 83 | Germ cell neoplasia (HP:0100728) | 2.34822441 |
| 84 | Asymmetry of the thorax (HP:0001555) | 2.26251748 |
| 85 | Microglossia (HP:0000171) | 2.24733340 |
| 86 | Hypoplasia of dental enamel (HP:0006297) | 2.23080996 |
| 87 | Renal tubular dysfunction (HP:0000124) | 2.22348720 |
| 88 | Hypomagnesemia (HP:0002917) | 2.17655178 |
| 89 | Broad distal phalanx of finger (HP:0009836) | 2.14661998 |
| 90 | Abnormality of molar (HP:0011077) | 2.14051435 |
| 91 | Abnormality of molar morphology (HP:0011070) | 2.14051435 |
| 92 | Abnormality of the frontal sinuses (HP:0002687) | 2.08745689 |
| 93 | Ventricular tachycardia (HP:0004756) | 2.08478514 |
| 94 | Macroorchidism (HP:0000053) | 2.08241469 |
| 95 | Natal tooth (HP:0000695) | 2.07706334 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07258461 |
| 97 | Alopecia of scalp (HP:0002293) | 2.04266768 |
| 98 | Palmoplantar hyperkeratosis (HP:0000972) | 2.02802519 |
| 99 | Spinal cord compression (HP:0002176) | 2.02693624 |
| 100 | Long toe (HP:0010511) | 2.01653465 |
| 101 | * Abnormality of cochlea (HP:0000375) | 11.5861785 |
| 102 | Abnormality of chloride homeostasis (HP:0011422) | 11.4602637 |
| 103 | Hypotension (HP:0002615) | 1.99031871 |
| 104 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.98872732 |
| 105 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.98818453 |
| 106 | Aplasia of the musculature (HP:0100854) | 1.98101091 |
| 107 | Hyperphosphaturia (HP:0003109) | 1.96420054 |
| 108 | Chondrocalcinosis (HP:0000934) | 1.93625415 |
| 109 | Flattened epiphyses (HP:0003071) | 1.92885808 |
| 110 | Distal upper limb amyotrophy (HP:0007149) | 1.92785190 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.92785190 |
| 112 | Esophageal varix (HP:0002040) | 1.92412355 |
| 113 | Abnormal drinking behavior (HP:0030082) | 1.91143949 |
| 114 | Polydipsia (HP:0001959) | 1.91143949 |
| 115 | Sparse eyelashes (HP:0000653) | 1.91136734 |
| 116 | Abnormality of purine metabolism (HP:0004352) | 1.90940974 |
| 117 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89932408 |
| 118 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.88378317 |
| 119 | * Hyperparathyroidism (HP:0000843) | 1.88120701 |
| 120 | Hypercortisolism (HP:0001578) | 1.87620088 |
| 121 | Hyperglycinuria (HP:0003108) | 1.87508024 |
| 122 | Hypoparathyroidism (HP:0000829) | 1.86833092 |
| 123 | Down-sloping shoulders (HP:0200021) | 1.86522053 |
| 124 | Abnormality of magnesium homeostasis (HP:0004921) | 1.84892565 |
| 125 | Onycholysis (HP:0001806) | 1.83993606 |
| 126 | Bicornuate uterus (HP:0000813) | 1.83764885 |
| 127 | Glycosuria (HP:0003076) | 1.83763318 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 1.83763318 |
| 129 | Abnormal blistering of the skin (HP:0008066) | 1.83234997 |
| 130 | * Vertigo (HP:0002321) | 1.82255609 |
| 131 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.81971316 |
| 132 | Hyperacusis (HP:0010780) | 1.81889791 |
| 133 | Bronchomalacia (HP:0002780) | 1.81719459 |
| 134 | Spinal muscular atrophy (HP:0007269) | 1.80695155 |
| 135 | Nephrolithiasis (HP:0000787) | 1.79572787 |
| 136 | Exostoses (HP:0100777) | 1.79492950 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 1.79457049 |
| 138 | Metabolic acidosis (HP:0001942) | 1.79133326 |
| 139 | Acanthosis nigricans (HP:0000956) | 1.78910187 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 1.78687861 |
| 141 | Abnormality of Sharpey fibers (HP:0100685) | 1.77853796 |
| 142 | Palmar hyperkeratosis (HP:0010765) | 1.77019156 |
| 143 | Popliteal pterygium (HP:0009756) | 1.75742183 |
| 144 | Abnormality of the salivary glands (HP:0010286) | 1.75702936 |
| 145 | Abnormal biliary tract morphology (HP:0012440) | 1.74870747 |
| 146 | Abnormal urine phosphate concentration (HP:0012599) | 1.74339641 |
| 147 | Abnormality of renal resorption (HP:0011038) | 1.73323981 |
| 148 | Nephrocalcinosis (HP:0000121) | 1.71902527 |
| 149 | Alveolar cell carcinoma (HP:0006519) | 1.66782686 |
| 150 | Stomach cancer (HP:0012126) | 1.62631438 |
| 151 | Tetany (HP:0001281) | 1.61577341 |
| 152 | Proximal tubulopathy (HP:0000114) | 1.57696253 |
| 153 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.53538627 |
| 154 | Increased purine levels (HP:0004368) | 1.50043443 |
| 155 | Hyperuricemia (HP:0002149) | 1.50043443 |
| 156 | Pili torti (HP:0003777) | 1.49150832 |
| 157 | Arterial tortuosity (HP:0005116) | 1.48824826 |
| 158 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.48034508 |
| 159 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.46395522 |
| 160 | Severe visual impairment (HP:0001141) | 1.39163406 |
| 161 | Pulmonary fibrosis (HP:0002206) | 1.37155449 |
| 162 | Abnormal number of incisors (HP:0011064) | 1.35979512 |
| 163 | Abnormality of glycine metabolism (HP:0010895) | 1.32236984 |
| 164 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.32236984 |
| 165 | Recurrent pneumonia (HP:0006532) | 1.31981242 |
| 166 | Spastic diplegia (HP:0001264) | 1.31905943 |
| 167 | Vascular tortuosity (HP:0004948) | 1.30092715 |
| 168 | Submucous cleft hard palate (HP:0000176) | 1.29118090 |
| 169 | Abnormality of the renal medulla (HP:0100957) | 1.28383945 |
| 170 | Hypoplasia of the iris (HP:0007676) | 1.27791601 |
| 171 | Generalized aminoaciduria (HP:0002909) | 1.27535205 |
| 172 | Bronchitis (HP:0012387) | 1.27530314 |
| 173 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.26269865 |
| 174 | Vomiting (HP:0002013) | 1.23006275 |
| 175 | Abnormality of the nasal septum (HP:0000419) | 1.19343552 |
| 176 | Protuberant abdomen (HP:0001538) | 1.18580384 |
| 177 | Abnormality of nucleobase metabolism (HP:0010932) | 1.18477274 |
| 178 | Tachypnea (HP:0002789) | 1.18367641 |
| 179 | Thin bony cortex (HP:0002753) | 1.17382899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRKG2 | 3.71221927 |
| 2 | SMG1 | 3.71064646 |
| 3 | WNK4 | 2.68504423 |
| 4 | STK39 | 2.51449634 |
| 5 | SIK1 | 2.37341517 |
| 6 | MAPKAPK3 | 2.11704345 |
| 7 | OXSR1 | 2.10386764 |
| 8 | VRK2 | 2.04108831 |
| 9 | FRK | 2.01915275 |
| 10 | LMTK2 | 14.7318431 |
| 11 | CDK12 | 1.97217121 |
| 12 | MATK | 1.91586136 |
| 13 | IRAK3 | 1.89400398 |
| 14 | ICK | 1.67667309 |
| 15 | NME1 | 1.65799609 |
| 16 | TAOK1 | 1.50670019 |
| 17 | MUSK | 1.47248216 |
| 18 | EEF2K | 1.44798354 |
| 19 | NEK6 | 1.38613001 |
| 20 | MAP3K3 | 1.37420553 |
| 21 | SCYL2 | 1.26819276 |
| 22 | PTK2 | 1.19851724 |
| 23 | WNK3 | 1.17749550 |
| 24 | DAPK2 | 1.17494083 |
| 25 | EPHA2 | 1.16259454 |
| 26 | MAP3K2 | 1.05917116 |
| 27 | TESK2 | 1.04140147 |
| 28 | PRKD2 | 1.03602869 |
| 29 | MTOR | 0.96875229 |
| 30 | TRIB3 | 0.91362550 |
| 31 | ERBB2 | 0.87344254 |
| 32 | LATS1 | 0.85669449 |
| 33 | FER | 0.85025398 |
| 34 | EPHB1 | 0.84901790 |
| 35 | SIK3 | 0.83126489 |
| 36 | IRAK2 | 0.82097545 |
| 37 | CSF1R | 0.81694665 |
| 38 | IKBKB | 0.76910348 |
| 39 | ROCK1 | 0.76446360 |
| 40 | CAMK2G | 0.75537343 |
| 41 | PRPF4B | 0.74911121 |
| 42 | ILK | 0.74417362 |
| 43 | MAP3K6 | 0.74103176 |
| 44 | MST4 | 0.74068446 |
| 45 | SGK223 | 0.72635215 |
| 46 | SGK494 | 0.72635215 |
| 47 | PRKAA1 | 0.71316042 |
| 48 | SGK2 | 0.70672291 |
| 49 | ERBB3 | 0.70456370 |
| 50 | SGK3 | 0.67557264 |
| 51 | PIM2 | 0.66205952 |
| 52 | NME2 | 0.62999572 |
| 53 | MAPKAPK2 | 0.62359890 |
| 54 | TBK1 | 0.59586610 |
| 55 | CAMK2B | 0.59533066 |
| 56 | TLK1 | 0.57666624 |
| 57 | PDK2 | 0.56819677 |
| 58 | CDK7 | 0.54227922 |
| 59 | EPHA3 | 0.54194914 |
| 60 | LRRK2 | 0.51959876 |
| 61 | MAP3K1 | 0.50080360 |
| 62 | RPS6KA1 | 0.49931047 |
| 63 | PKN2 | 0.49491677 |
| 64 | MAPK15 | 0.48075706 |
| 65 | WNK1 | 0.47991684 |
| 66 | MARK2 | 0.47896027 |
| 67 | PRKCE | 0.46650660 |
| 68 | MAP3K11 | 0.46175007 |
| 69 | ADRBK1 | 0.45366060 |
| 70 | DYRK3 | 0.44784600 |
| 71 | RPS6KB1 | 0.41399028 |
| 72 | IRAK4 | 0.41318455 |
| 73 | RPS6KL1 | 0.41102368 |
| 74 | RPS6KC1 | 0.41102368 |
| 75 | DYRK1B | 0.40613180 |
| 76 | PTK6 | 0.40502213 |
| 77 | SRPK1 | 0.39846955 |
| 78 | MELK | 0.38751928 |
| 79 | DAPK1 | 0.37871241 |
| 80 | CAMK2D | 0.36835013 |
| 81 | CAMKK1 | 0.36796229 |
| 82 | EIF2AK1 | 0.35481520 |
| 83 | RIPK1 | 0.35146564 |
| 84 | TRPM7 | 0.35058327 |
| 85 | BLK | 0.34683097 |
| 86 | STK38L | 0.34009059 |
| 87 | UHMK1 | 0.33530810 |
| 88 | MAP2K1 | 0.33180278 |
| 89 | MET | 0.33069196 |
| 90 | BMX | 0.32071742 |
| 91 | ERN1 | 0.31304346 |
| 92 | NUAK1 | 0.30346623 |
| 93 | DYRK1A | 0.29229630 |
| 94 | CDC42BPA | 0.29013598 |
| 95 | HIPK2 | 0.28957950 |
| 96 | BCKDK | 0.28887428 |
| 97 | CDK9 | 0.28579623 |
| 98 | MAPK8 | 0.27333412 |
| 99 | MAP2K2 | 0.26912768 |
| 100 | ARAF | 0.26816650 |
| 101 | STK10 | 0.26753911 |
| 102 | BMPR2 | 0.26703370 |
| 103 | CSNK1A1L | 0.26588965 |
| 104 | FGFR4 | 0.24864158 |
| 105 | CDK8 | 0.24595395 |
| 106 | CAMK1G | 0.23553326 |
| 107 | CAMK4 | 0.23443131 |
| 108 | PRKD1 | 0.23378602 |
| 109 | AURKA | 0.21658872 |
| 110 | DMPK | 0.21481498 |
| 111 | IRAK1 | 0.21220892 |
| 112 | RPS6KA4 | 0.19413838 |
| 113 | CAMK1D | 0.19253675 |
| 114 | GRK6 | 0.19061873 |
| 115 | CSNK1G1 | 0.18464088 |
| 116 | PRKCH | 0.17962245 |
| 117 | PIK3CA | 0.17605993 |
| 118 | KSR2 | 0.17297636 |
| 119 | STK38 | 0.17011196 |
| 120 | ROCK2 | 0.16333679 |
| 121 | TESK1 | 0.15751824 |
| 122 | CDK6 | 0.15566995 |
| 123 | PAK3 | 0.15508913 |
| 124 | SIK2 | 0.15371719 |
| 125 | PRKCD | 0.14832141 |
| 126 | RPS6KA2 | 0.14685769 |
| 127 | LATS2 | 0.13336831 |
| 128 | RPS6KB2 | 0.12496303 |
| 129 | PRKACG | 0.12483543 |
| 130 | CHUK | 0.11739248 |
| 131 | GSK3A | 0.11609712 |
| 132 | RET | 0.11386357 |
| 133 | PRKG1 | 0.10792932 |
| 134 | AKT2 | 0.10664372 |
| 135 | PAK4 | 0.10232558 |
| 136 | BRD4 | 0.10183179 |
| 137 | CSNK1G3 | 0.10026022 |
| 138 | PDPK1 | 0.09306955 |
| 139 | DAPK3 | 0.09189469 |
| 140 | MST1R | 0.08917503 |
| 141 | TTN | 0.08707493 |
| 142 | CSNK1G2 | 0.08061767 |
| 143 | SGK1 | 0.07808666 |
| 144 | PRKCZ | 0.07553578 |
| 145 | MAP3K7 | 0.07284304 |
| 146 | JAK1 | 0.07176936 |
| 147 | DDR2 | 0.07139921 |
| 148 | PRKCI | 0.06828491 |
| 149 | RPS6KA6 | 0.06814484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 4.31459335 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.00006477 |
| 3 | Thyroid cancer_Homo sapiens_hsa05216 | 2.76070652 |
| 4 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.71460121 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.60030079 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.56328137 |
| 7 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.46904386 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.24642876 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 2.15784638 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02780469 |
| 11 | ABC transporters_Homo sapiens_hsa02010 | 2.02427110 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.96102573 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95221441 |
| 14 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.94810267 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91546903 |
| 16 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.90629491 |
| 17 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.86936294 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83356870 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73192232 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73121440 |
| 21 | Hepatitis C_Homo sapiens_hsa05160 | 1.72036147 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.70542368 |
| 23 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.68985309 |
| 24 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.68513613 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.63286019 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.63170307 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.60506149 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60480499 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.59011249 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54826531 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54619056 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53057548 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52177261 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51533603 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48966808 |
| 36 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.46968113 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.45287933 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.42428113 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.42184652 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.41333373 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34491299 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34301332 |
| 43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.33116927 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.33065398 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.31428368 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31239827 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.29978931 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28354445 |
| 49 | Melanoma_Homo sapiens_hsa05218 | 1.27800119 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26683334 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23176025 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.22429842 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21981063 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 1.17631243 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15334506 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14675970 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.14361205 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12025685 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 1.08589152 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08403945 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 1.08182700 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03758805 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.98759466 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.97664345 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96702519 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92682051 |
| 67 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89226876 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88547258 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88072258 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.87413853 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86163519 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82245666 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81472967 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80659194 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.80328225 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80117965 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79852103 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79266096 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.78706466 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78313218 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77052187 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76064472 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74878129 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.73957434 |
| 85 | Salivary secretion_Homo sapiens_hsa04970 | 0.73805280 |
| 86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73529500 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73130578 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72660038 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69686306 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68089021 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.65025307 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.63015195 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62077090 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62058499 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61506029 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61315378 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.60774853 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60392286 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60255086 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60119025 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59387790 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57624780 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55992277 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.55911893 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55600399 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55474087 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55435387 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54480507 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.53809495 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53770808 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53159596 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51777757 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51773378 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50913570 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50780643 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50242009 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.49943608 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49740437 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48655973 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.48538225 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48427758 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48352660 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48000953 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47472637 |
| 125 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47306043 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46880432 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46034213 |
| 128 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44700034 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.44390313 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44132081 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43426757 |
| 132 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43351556 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42601852 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42507984 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42132962 |
| 136 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41799402 |
| 137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41771212 |
| 138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41720518 |
| 139 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41636098 |
| 140 | Phagosome_Homo sapiens_hsa04145 | 0.41489413 |
| 141 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41117551 |
| 142 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41048761 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | 0.39687872 |
| 144 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39639863 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39521828 |
| 146 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39473470 |
| 147 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38312642 |
| 148 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38164010 |
| 149 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37081607 |
| 150 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37046924 |
| 151 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36791221 |
| 152 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36598766 |
| 153 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35001054 |
| 154 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34519496 |
| 155 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33291391 |
| 156 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33184252 |
| 157 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32987602 |
| 158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32564643 |
| 159 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32066008 |

